|Original language||English (US)|
|Journal||Circulation: Cardiovascular Interventions|
|State||Published - 2018|
- Acute kidney injury
- Blood transfusion
- Transcatheter aortic valve replacement
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
In: Circulation: Cardiovascular Interventions, Vol. 11, No. 11, e007517, 2018.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Trends in inpatient complications after transcatheter and surgical aortic valve replacement in the transcatheter aortic valve replacement era
AU - Arora, Sameer
AU - Strassle, Paula D.
AU - Qamar, Arman M.D.
AU - Kolte, Dhaval
AU - Pandey, Ambarish
AU - Paladugu, Madhu B.
AU - Borhade, Mahesh B.
AU - Ramm, Cassandra J.
AU - Bhatt, Deepak L.
AU - Vavalle, John P.
N1 - Funding Information: funded by Daiichi Sankyo), Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Vice-Chair, ACC Accreditation Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial (Randomized Evaluation of Dual Antithrombotic Therapy With Dabigatran Versus Triple Therapy With Warfarin in Patients With Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) steering committee funded by Boehringer Ingelheim), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (for the Cardiovascular Outcomes for People Using Anticoagulation Strategies [COMPASS] operations committee, publications committee, steering committee, and USA national coleader, funded by Bayer), Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), National Cardiovascular Disease Registry-ACTION Registry Steering Committee (Chair), Veterns Affairs Clinical Assessment Reporting and Tracking (VA CART) Research and Publications Committee (Chair); Research Funding: Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, Synaptic, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St Jude Medical (now Abbott), Svelte; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, Novo Nordisk, PLx Pharma, Takeda. Dr Qamar is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant (T32HL007604), the American Heart Association Strategically Focused Research Network in Vascular Disease grant (18SFRN3390085 & 18SFRN33960262), research grants to his institution from Daiichi Sankyo and fees for CME programs from Medscape. P.D. Strassle has received salary support from researchEZ LLC, and Dr Arora’s spouse has proprietary role in researchEZ LLC. C.J. Ramm serves on an advisory board for Boston Scientific. The other authors report no conflicts.
PY - 2018
Y1 - 2018
KW - Acute kidney injury
KW - Blood transfusion
KW - Incidence
KW - Mortality
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85058911000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058911000&partnerID=8YFLogxK
U2 - 10.1161/CIRCINTERVENTIONS.118.007517
DO - 10.1161/CIRCINTERVENTIONS.118.007517
M3 - Letter
C2 - 30571211
AN - SCOPUS:85058911000
SN - 1941-7640
VL - 11
JO - Circulation: Cardiovascular Interventions
JF - Circulation: Cardiovascular Interventions
IS - 11
M1 - e007517